Posted by AGORACOM
at 9:04 AM on Thursday, December 24th, 2020
PEAK Provides Update On 2017 Secured Debentures and Exercise of Warrants
Secured debentures issued back in December, 2017, originally totaling $12-million and of which a balance of $3.27-million was still outstanding as on Oct. 1, 2020, have totally been paid back by Peak Fintech Group Inc. or converted into common shares of the company.
The debentures were issued in the course of a private placement financing where the company sold a total of 1,200 units for gross proceeds of $12-million. Each unit sold comprised a $10,000 face value, two-year maturity, 8-per-cent annual interest secured debenture plus 20,000 common share purchase warrants. The maturity was extended by another year in 2019 and the debentures were set to mature on Dec. 16, 2020. Investors who purchased the units could, at any time prior to the maturity date of the debentures, surrender part or all of the amount invested in the debentures to exercise their warrants and purchase common shares of the company at a price of 50 cents per share. In summary, $11.94-million of the debentures was surrendered to exercise warrants and the company paid back $60,000 in cash to investors.
In addition to the warrants exercised as a result of the surrender of the debentures, the company received over $2.5-million in cash from the exercise of warrants unrelated to the debentures between Oct. 1, 2020, and Dec. 23, 2020.
About Peak Fintech Group Inc.
Peak Fintech is the parent company of a group of innovative financial technology (fintech) subsidiaries operating in China’s commercial lending industry. Peak’s subsidiaries use technology, analytics and artificial intelligence to create an ecosystem of lenders, borrowers and other participants in China’s commercial lending space, where lending operations are conducted rapidly, safely, efficiently and with the utmost transparency.
Posted by AGORACOM
at 12:08 PM on Wednesday, December 23rd, 2020
Gratomic Inc. (“GRAT” or the “Company”) (TSXV:GRAT)(OTCQB:CBULF)(FRANKFURT:CB81)(WKN:A143MR) announces the arrival of both the custom-built Material Hopper and Graphite Chipper to the Aukam mine site from South Africa. Excavation and preparations on the foundations for the Filter Press, Chipper, Cyclone, and Material Hopper have been successfully completed.
Two separate foundations were constructed to accommodate the commercial Filter Press. The equipment will be strategically placed one meter from the base of the product thickener tank. This will establish the shortest distance between the equipment for the graphite concentrate slurry to effectively enter the filter press from the product thickener tank. The press will be fitted onto two separate steel legs, with a custom-built catwalk surrounding the entire unit. This ensures staff safety when working around and servicing the equipment. Upon securing the Filter Press on the new foundations, a conveyor will be positioned below the output of the Press and placed at a 12° angle to more efficiently feed the graphite cake concentrate into the material chipper.
At 16 feet long, the Filter Press will have the capacity to process 5 tonnes of graphite concentrate per hour and will reduce the moisture content up to 92% before the concentrate enters the custom-built chipper. It will then make its way from the chipper into the rotary drying unit. Water that has been extracted from the filter press will be routed back to the settling reservoir tanks. From there it will be recirculated through the custom designed water filtration and deionization unit for continued use in the commercial processing plant. The Filter Press is a large component of the Company achieving its goal of a 95% water recycling rate during the graphite processing phase.
The company’s custom-built material chipper will be placed on a separate concrete foundation from the filter press. A two-tonne capacity hopper has been constructed adjacent to the chipper’s output to supply a continuous feed of graphite cake material to the rotary dryer unit. These components will complete the drying circuit of the Aukam 20,000 tonnes per annum commercial graphite processing plant.
The Material Hopper foundation work has been completed in conjunction with the cyclone foundation work. Once the concrete has cured, the custom-built hopper will be installed and mounted onto its new foundation. A supply conveyor will be installed and positioned to feed the material hopper with graphite containing material from the previously installed crushing and screening circuit. The variable speed drive screw conveyor (VSD) that is mounted inside the hopper will be positioned to feed the already installed commercial-sized rod mill. The material hopper is designed to hold 80 tonnes of material to allow for a 1 and a half days’ supply buffer to the processing plant (see press release November 20th, 2020).
“As the final construction is being completed on the Company’s custom-built processing plant, we would like to once again thank all of our mine workers, employees, contractors, and manufacturers, both on and off site, for all of their continued hard work and support.” says President and CEO, Arno Brand.
“The careful studies and analysis that based the engineering design of these exclusive, custom built pieces of equipment, will continue to ensure that Gratomic takes all necessary steps to deliver operational excellence at a benchmark level in the graphite industry”, says Amrando Farhate, COO & Head of Graphite Marketing and Sales.
About Gratomic Inc.
Established in 2014, Gratomic is an advanced materials company focused on low-cost mine to market commercialization of carbon-neutral, Eco-friendly, high purity vein graphite and is set to become a key player in EV and Renewable Resource supply chains. Gratomic Inc. is a leader among peers, anticipating full operational capabilities in late 2020 and aiming to transition to an open pit operation as early as the end of 2021.
Gratomic is in the process of solidifying its development plans for micronization and spheronization of its clean Aukam graphite. This significant milestone is a small, additional step in the Company’s existing Eco-friendly processing cycle and will allow its naturally high purity graphite to meet ideal North American battery grade standards for use in Li-ion battery anodes.
The Company promises to deliver mine-to-market traceability and guaranteed quality control. This will be accomplished by providing documented tracking on all graphite generated at its flagship Aukam Graphite Project. The tracking will begin at Aukam and will be verified at every stage during transport.
Two off-take purchase agreements are currently held for lump-vein graphite sourced from Gratomic’s Aukam Graphite Project in Namibia, Africa. Fulfillment of the contracts is slated to begin in 2021. The agreements exist with TODAQ and Phu Sumika.
TODAQ is an innovative tech company and will partner with Gratomic on its mine-to-market commodity tracking.
Phu Sumika is a large global graphite supplier to battery and lubrication companies.
Gratomic Inc. is listed on the TSX Venture Exchange under the symbol GRAT.
For more information: visit the website at www.gratomic.ca or contact:
“Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”
Forward Looking Statements:
This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR in Canada (available at www.sedar.com).
Posted by AGORACOM-JC
at 11:48 AM on Wednesday, December 23rd, 2020
Announced a $750,000 order for its continuous emissions business which includes BioCloudTM units and a separate initial order from one of Ontario’s largest Electricity Generators
The continuous emissions and BioCloud revenues are anticipated to be recorded in Q1 2021
TORONTO, ON / December 23, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce a $750,000 order for its continuous emissions business which includes BioCloudTM units and a separate initial order from one of Ontario’s largest Electricity Generators. The continuous emissions and BioCloud revenues are anticipated to be recorded in Q1 2021.
“We are very pleased to receive a significant order in our core business with a US manufacturing customer which also includes 2 BioCloud units as part of a package sale,” says Paul Ghezzi, CEO of Kontrol. “Our corporate strategy is to quote BioCloud units as part of all new sales opportunities from our core business. In addition, we are pleased that one of Ontario’s largest Electricity Generators has ordered an initial 2 units of BioCloud. Both customers have additional scale potential with numerous facilities. Our recent product launch and technology walk-through in December was a success and has initiated accelerating interest in how BioCloud can help create safer spaces.”
Distribution Orders
To date the Company has received 40 initial distribution orders for delivery in January from its existing distribution network. The Company has entered into 6 distribution agreements (1 exclusive and 5 non-exclusive) and is in negotiations for various potential additional non-exclusive distributions agreements. Distribution is a key part of our go to market strategy that can allow the Company to scale quickly.
“In a short period of time since the official launch of BioCloud in December we have received strong interest and numerous distribution requests,” says Gary Saunders, VP Kontrol. “We envision many more agreements across the globe as we focus on growing the BioCloud business.”
As the Company continues to build its distribution business, we anticipate that distributors will be required to maintain a minimum of 250-unit sales per annum to retain non-exclusivity and distributor pricing. The Company’s internal goal is to have 30 regional distributors established by the end of Q1 2021.
Customer Pilots
The Company plans to begin numerous pilots with both existing customers of Kontrol and new potential customers. The purpose of the pilots is to provide potential customers with various specific application use cases across their facilities. The types of pilot customers will include the sectors of commercial real-estate, grocery stores, franchised restaurants, educational facilities and other. Subject to pilot customer approval Kontrol may announce customer pilots or may operate them under non-disclosure agreement.
Recurring Revenue
The BioCloud unit operates with a proprietary detection chamber. The retail price for the detection chamber consumable will range from $400 to $500 and the recommended replacement is three times per year or whenever the detection chamber comes into contact with SARS-CoV-2. Customers that purchase multiple units will receive volume discounts for the detection chamber.
Re-Agent Supply Chain
The detection chamber includes a specific re-agent system. To date the Company has been sourcing its re-agents from the United States. The Company has initiated discussions and testing to source its re-agents from Canadian based sources. By doing so it is seeking to add more of its supply chain in Canada but also reduce the costs of the detection chamber. Further updates will be provided following additional testing.
Essential Service
Kontrol and its manufacturing supply chain operate as an Essential Service provider and do not anticipate being impacted by applicable COVID-19 shutdowns.
About Kontrol BioCloudTM
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.
Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com
BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.
About Kontrol Energy
Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com
For further information, contact:
Paul Ghezzi, Chief Executive Officer [email protected] or [email protected] Kontrol Energy Corp. 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Posted by AGORACOM-JC
at 11:34 AM on Wednesday, December 23rd, 2020
Announced that it has closed its previously announced brokered private placement of units of the Company, pursuant to which the Company issued 7,666,667 Units at a price of $0.15 per Unit for aggregate gross proceeds of $1,150,000
The Offering was led by Mackie Research Capital Corporation as sole agent and sole bookrunner
TORONTO, ON / December 23, 2020 /KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America” or “KABN NA“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has closed its previously announced brokered private placement of units of the Company (the “Units“), pursuant to which the Company issued 7,666,667 Units at a price of $0.15 per Unit (the “Offering Price“) for aggregate gross proceeds of $1,150,000 (the “Offering“). The Offering was led by Mackie Research Capital Corporation as sole agent and sole bookrunner (the “Agent“).
Each Unit is comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant is exercisable to acquire one Common Share (a “Warrant Share“) at an exercise price of $0.20 per Warrant Share, for a period of 24 months from the closing of the Offering.
The Company intends to use the net proceeds raised under the Offering for working capital and general corporate purposes.
In connection with the Offering, the Agent received an aggregate cash fee equal to 8.0% of the gross proceeds from the Offering including in respect of any exercise of the Agent’s Option. In addition, on closing the Company granted the Agent non-transferable compensation options (the “Compensation Options“) equal to 8.0% of the total number of Units sold under the Offering (including in respect of any exercise of the Agent’s Option). Each Compensation Option entitles the holder thereof to purchase one Unit at an exercise price equal to the Offering Price for a period of 24 months following the Closing.
In addition, the Company has paid the Agent a financial advisory fee satisfied by the issuance of 830,000 Common Shares.
The securities issued pursuant to the Offering are subject to a four-month and one day hold period under applicable securities laws in Canada.
The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.
About KABN North America
KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from the use of their online identity. KABN NA’s propriety technology suite includes 4 key products:
Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allow users to manage and control their Self Sovereign Identity and to use Liquid Avatars to share verifiable credentials, including access, identity and designation credentials, and public and permission based private data when they want and with whom they want. www.liquidavatar.com
KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.
KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com
KABN KASH is a cashback, loyalty and engagement program that powers the KABN NA’s revenue ecosystem. KABN NA provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the proposed use of the net proceeds of the Offering.
By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
As the name implies “PropTech” is a combination of two words and stands for “property technology.” As simple as that is, the implementation and importance of PropTech is anything but.
Like every other industry on the planet that is incorporating technology to create greater efficiencies and experiences, the commercial real estate market is no different and is seeing the rapid adoption of;
Artificial Intelligence
Machine learning
Big data
Internet of Things (IoT Sensors)
Cloud computing
To create cost savings by reducing and even eliminating existing costs, create greater efficiencies for the operation and maintenance of real estate assets, as well as, improve the design of new builds.
IMPACT OF COVID-19
The COVID-19 pandemic has served to significantly increased the demand for PropTech in the commercial real estate market as follows:
The need for solutions to get workers back into workplace buildings and offices. Specifically, the need to identify bacteria and viruses in indoor air quality, as well as, the ability to sanitize immediately and effectively.
The need to create even greater cost savings and efficiencies for real estate owners that will continue suffering losses until workers significantly return to the workplace.
WHY UNIVERSAL PROPTECH (UPI:TSXV)?
Whereas many companies are just now trying to capitalize on the opportunities presented in the current and massive future of PropTech, Universal PropTech Inc. (“UPI”) a diversified investment platform delivering healthy building solutions and services for building developers, owners and operators in Canada. More than just lip service, UPI has been successfully delivering its PropTech solutions for years, with revenues over the last 3 years as follows:
2017 – $13.8M
2018 – $13.7M
2019 – $15.9M
Headquartered in Toronto, UPI has offices across Canada including Halifax,Montreal, and Ottawa.
COMPANY HIGHLIGHTS
Used in Federal Government facilities for over 40 years
Provides real estate managers turnkey HVAC Building Controls design, equipment, installation and ongoing operations and maintenance services for Industrial, Commercial, Institutional and Multi-residential customers
Already possesses under-utilized IP in building controls to add in additional monitoring inputs and equipment controls
Diverse revenue streams via products, installations and ongoing
Key strategic partnerships afford the ability to monitor real-time utility meters, key BAS and systems data in a building.
Team has the capability to make sense of this data and apply advanced web tools to make recommendations to fine tune a building, saving from 5% to 15% of a facilities energy spend without capital expenditure
VCI offers the depth and breadth of Building Automation Systems (BAS) knowledge and products from the likes of Siemens and Honeywell to support building automation systems
As businesses return to the office, property managers must think about the design and safety of their buildings for occupants. Traditional cleaning methods are ineffective at preventing transmission. UV technology is able to sanitize all surfaces free from pathogens. UPI is capitalizing on this opportunity by building and acquiring UV technology as it is the best in the market to administer and integrate it into healthy buildings in Canada.
Posted by AGORACOM
at 8:46 AM on Wednesday, December 23rd, 2020
VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) — Candente Gold Corp. (TSXV:CDG) (“Candente Gold” and/or the “Company”) is pleased to announce that technical experts have been engaged for permitting and deposit modelling for the El Dorado and Cocula projects and for permitting for the San Dieguito de Arriba (“SDA”) plant. Claudia Santos of Consultoría Ambiental VUGALIT S.C. will be handling permitting with Barney Lee, of Mingeo International S.A. de C.V.
Yenlai Chee, of Mountain Goat Consulting, is developing three dimensional models for the El Oro, Cocula and El Dorado mineral deposits to assist in understanding the deposits and in identifying higher grade zones.
Cocula Gold Project
The Company recently signed the Definitive Agreement for profit sharing on the Cocula Gold Project which gives Candente Gold the right to receive 70% of profits that may be derived from mining and processing of the deposit. Upon signing this agreement, a second payment of US$20,000 was made to the owners of the property.
Grades of 5.66 grams per tonne (“g/t”) gold over 6 metres and 4.32 g/t gold over 8 metres occur in quartz breccia bodies in an oxidized zone that to date has been delineated over an 800 metre length and 54 metre depth. Metallurgical testing indicates that this portion of the deposit is expected to be amenable to either heap, vat or dynamic (agitation) leaching.
In addition, higher grade mineralization associated with sulphides is also known to occur in veins at Cocula. Grades of 59 g/t gold and 729 g/t silver were obtained from a selected sample over a 10 centimetre (“cm”) width in the hanging wall of a quartz vein-breccia structure near the portal of a collapsed adit. This style of mineralization will be further explored for the potential for mineralization that could be amenable to flotation and processed at our SDA plant.
The Cocula Project area is located within the Ameca Mining District of Jalisco State which is home to Agnico Eagle’s El Barqueño Project, Endeavor Silver’s Terronera Project and GoGold’s Los Ricos Project. Please see News Releases dated September 10th and October 22nd, 2020 as well as http://www.candentegold.com/s/cocula.asp for further details on the Cocula Project.
SDA Plant and El Dorado
The Company has received final TSX Venture Exchange (“TSXV”) approval for the Definitive Agreement to acquire the SDA plant and the rights to an agreement on the El Dorado property from Magellan Acquisition Corp. (“Magellan”). The company is issuing 5,000,000 shares for Magellan’s rights to the El Dorado property and to obtain the first 10% interest in the SDA plant. The Definitive Agreement also gives Candente Gold the right to earn up to 100% interest in the plant by issuing shares in stages over 30 months totaling a value of US$1.425 million. Magellan has also agreed that the total number of shares to be issued for the 100% interest will not exceed 33,500,000.
SDA Plant
The SDA plant consists of a flotation plant which also includes a precious metals leach circuit – Merrill Crowe system and associated assets, licenses and agreements. The plant lies within the rich Sierra Madre Occidental mineralized belt, which historically has yielded millions of ounces (“oz”) of precious metals and offers multiple high-grade gold and silver epithermal vein opportunities. For further details, please see News Releases dated April 28 and September 28, 2020 as well as http://www.candentegold.com/s/sda.asp.
El Dorado
The El Dorado Gold-Silver Project is located in the Pacific Coastal Plain, State of Nayarit, within a district of epithermal vein systems which is known to host high grade gold and silver in several veins.
The El Dorado vein system has a history of small-scale mining from two veins and is reported to extend over 3.5 km. Within this system, a mineralized zone 400 meters long and up to 180 meters to depth has been delineated by drilling by previous explorers. Average grades are reported to be in the ranges of 4.4 to 9.8 grams per tonne (“g/t”) gold and 113 to 239 g/t silver, however, drilling has intersected grades ranging from 3.0 to 40.0 gold and 57 to 500 g/t silver over widths ranging from 0.52 meters to 11.2 meters. Silver, lead, zinc and copper mineralization also occurs in the Cocula deposit and is expected to provide secondary credits.
The El Dorado property lies 50 km south of the SDA Plant. The project has excellent road and rail infrastructure. For further details, please see News Releases dated April 28 and September 28, 2020 as well as http://www.candentegold.com/s/eldorado.asp.
AGM
The Company is pleased to report that all matters submitted to the shareholders for approval as set out in the Company’s Notice of Meeting and Information Circular, dated November 13, 2020, were approved at the Annual Meeting of Shareholders held on December 18th, 2020 in Vancouver (the “AGM”). A total of 34,356,926 shares were voted, representing 31.17% of total shares issued and outstanding as of the record date of the Meeting.
All of the current Directors: Joanne C. Freeze, Larry D. Kornze, Ian Ward, Mark Lotz and Matthew Melnyk were re-elected. Shareholders also voted in favour of (i) appointing Davidson & Company LLP, Chartered Professional Accountants as auditors of the Company for the ensuing year and authorizing directors to fix their remuneration; (ii) approving the Company’s Stock Option Plan of the Company; and (iii) approving Other Business that may properly come before the meeting or any adjournment or adjournments thereof.
Xali Gold Corp.
The Company also advises that it plans to change its name to Xali Gold Corp. in early 2021 which will include both a change of trading symbol and CUSIP number. The Company will advise the actual date for the change once all of the above is confirmed.
About Candente Gold
Candente Gold has launched a comprehensive growth strategy to build a cash flowing business platform and gain access to properties with near surface exploration potential while maintaining El Oro as its flagship asset and an integral part of the overall growth strategy. The acquisition of the SDA Plant, the El Dorado historic mines and the Cocula Project signify important initial steps.
The financial benefits from Western Mexico operations and the addition of specialized personnel will translate across platforms to strengthen the Company’s efforts to explore and potentially mine areas demonstrated to contain mineralization of value. The Company is currently evaluating other properties that are complementary to the SDA plant, El Dorado and the Cocula Project.
El Oro is a district scale gold project encompassing a well-known prolific high-grade gold dominant gold-silver epithermal vein system in Mexico. The project covers 20 veins with past production and more than 57 veins in total, from which approximately 6.4 million ounces of gold and 74 million ounces of silver were reported to have been produced from just two of these veins (Ref. Mexico Geological Service Bulletin No. 37, Mining of the El Oro and Tlapujahua Districts. 1920, T. Flores*)
Modern understanding of epithermal vein systems indicates that several of the El Oro district’s veins hold excellent discovery potential, particularly below and adjacent to the historic workings of the San Rafael Vein, which was mined to an average depth of only 200 metres.
Joanne C. Freeze, P.Geo., President, CEO and Director and Matthew Melnyk, CPG., Director Operations and Director are Qualified Persons as defined by National Instrument 43-101 for the projects discussed above, however, they have not been able to visit the El Dorado or Cocula Projects nor the SDA Plant recently due to COVID virus travel restrictions. The work discussed in the News Release is either historical and documented by public records or conducted by Mexican professionals with qualifications similar to those of QP’s registered in Canada. Ms. Freeze and Mr. Melnyk have reviewed and approved the contents of this release.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM
at 8:42 AM on Wednesday, December 23rd, 2020
December 23, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company”) is pleased to announce that it has hired Wellington-Dupont Public Affairs (“Wellington-Dupont“) to provide government relations support and lobbying services on behalf of the Company. Wellington-Dupont has approached the Government of Canada in the hopes of initiating first steps for Red Light Holland to receive an exemption for controlled substances use as part of clinical studies, in order to safely analyze the potential positive impacts of psilocybin on mental health.
“We have a big idea. But we need to carefully proceed, in order for it to hopefully come to fruition,” said Red Light Holland CEO and director Todd Shapiro. “This is why we have hired expert lobbying and government relations firm, Wellington Dupont Public Affairs. Through Wellington Dupont, we look forward to engaging the federal government to discuss the usage of natural psilocybin products, and their potential benefits.”
“We are pleased to represent Red Light Holland as they seek an exemption for controlled substances use as part of a clinical study,” said Summer Senter, Consultant Lobbyist at Wellington-Dupont Public Affairs. “Together we are working with another group to build a detailed plan that will lead to potentially ground-breaking and positive change in Canada. We look forward to sharing more news, when appropriate.”
About Wellington Dupont
Wellington Dupont is a North American public affairs firm with strong talent working closely across Canada and the United States. With offices across Canada and the United States, Wellington Dupont’s approach ensures consistent and seamless results throughout all offices while keeping top of mind policy and regulations on both sides of the border.
Wellington Dupont’s team of trusted advisors uses their combined experience in media relations, business, politics, and government to provide sound counsel and strategic advice while helping clients achieve results.
Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.
Posted by AGORACOM-JC
at 7:52 AM on Wednesday, December 23rd, 2020
Expanding from the successful launch in medical-only channels in partnership with Medical Cannabis by Shoppers, Avicanna will now offer RHO Phyto™ nationwide through provincial retailers
RHO Phyto products will include its advanced formulary of sublingual sprays, oil drops and topicals through retail sales channels estimated at $3 billion dollars* in Canada
TORONTO, Dec. 23, 2020 — Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announces that the full formulary of RHO Phyto products will be available through retail channels in early 2021 in Canada.
A successful proof of concept and partnership with Medical Cannabis by Shoppers
During the past four months, the RHO Phyto medical formulary has experienced an incredibly successful launch with overwhelming positive support by the medical community including 300 prescribers and 20 clinics. RHO Phyto sales have increased 100%+ month over month in all product categories. The early results show the product formulary key demographics are 55% women, 47% are 51-75 years of age and 90% of consumers are 30+ years old. Avicanna will remain exclusive to Medical Cannabis by Shoppers for medical/prescription use and intends to increase its current commercial SKU’s from 4 to 10 in 2021.
Expansion to retail sales to provide consumers with low barrier access to the same industry leading formulary of medical cannabis products
It has become evident that many consumers who seek cannabis for medical purposes are not going through medical channels, with nearly 44% purchasing from legal storefronts (adult-use). According to the 2020 Canadian Cannabis Survey, 76% of medical cannabis users do not have a medical document – such as a prescription – from a healthcare professional. The ease of access to store-fronts and systemic barriers to connecting with a health care professional who may provide a medical document have continued to impact medical user numbers year over year, which have remained largely the same around 350,000 active registered medical users in Canada since 2018*.
Aras Azadian, Avicanna’s Chief Executive Officer, stated: “The existing stigma around medical cannabis and the barriers to obtain a medical document make it particularly challenging for some patients to access medical cannabis through the appropriate channels with the support of a health care practitioner. We believe that by expanding the RHO Phyto portfolio into retail sales channels we will provide consumers with easier and low barrier access to standardized medical products they seek. For a biopharmaceutical company like Avicanna, this expansion of our medical products into retail channels is in many ways similar to accessing over-the-counter medical products.” Aras Azadian, the companies Chief Executive Officer.
RHO Phyto product attributes and retail sales strategy
The advanced and standardized products are offered in various doses of CBD, THC and THC-Free formulations to provide consumers with a range of inhalation-free cannabinoids-based solutions. The advanced formulations are developed and optimized by Avicanna to provide enhanced absorption versus basic MCT (medium-chain triglyceride) oil formulations while providing a consistent experience with a pleasant taste and smell. The RHO Phyto products are delivered with accurate dosing which also allows for easy titration and dosing by consumers.
Avicanna’s RHO Phyto strategy to leverage retail sales channels is consistent with the company’s vision to provide education and safe delivery of its products through evidenced-based training and education to the consumers, retailers and the medical community. Avicanna aims to establish RHO Phyto as the doctor recommended brand within the cannabis industry and has initiated several pre-clinical and real-world evidence clinical trials on the products with leading Canadian medical institutions.
*source: Statistics Canada
About Avicanna Inc.
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:
Pura Earth™ or Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all 2 developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.
With ongoing clinical trials on its derma-cosmetic (branded as Pura Earth or Pura H&W), medical cannabis (branded as RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.
Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.
SOURCE Avicanna Inc.
Stay Connected
For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].
Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of the Company to manufacture any of the products, and the ability of the Company to sell any of the products in retail channels in Canada. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020 and final short form prospectus dated November 27, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR atwww.sedar.com.
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM-JC
at 7:14 AM on Wednesday, December 23rd, 2020
Announced today its plant-based toddler nutrition product will be available for purchase at Sprouts Farmers Market in February 2021
Consumers seeking healthy plant-based alternatives for their toddlers, will soon be able to find ELSE’s complete Toddler Nutrition product in over 360 Sprouts locations nationwide
VANCOUVER, BC , Dec. 23, 2020 /- ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”) , a provider of plant-based alternatives to dairy-based baby nutrition, announces today its plant-based toddler nutrition product will be available for purchase at Sprouts Farmers Market in February 2021 .
Consumers seeking healthy plant-based alternatives for their toddlers, will soon be able to find ELSE’s complete Toddler Nutrition product in over 360 Sprouts locations nationwide. The organic formula is primarily made of almonds, tapioca and buckwheat; three core ingredients that go through a clean, all-natural process that offers the protein, carbohydrates, and fat directly from the whole plants, along with phytonutrients, fiber, vitamins and minerals nature intended to provide optimal nourishment for children. Else is free of dairy, soy and corn-syrup, and is made with non-GMO ingredients.
“Being on the shelves at Sprouts Farmers Markets is an incredible milestone for our brand,” said Ms. Hamutal Yitzhak , CEO and Co-Founder of Else. “We are appreciative of the belief and support Sprouts has shown in our line of products, as they become the first natural grocery account to distribute Else on a national level. We have our sights set on being highly accessible across the United States , and this will begin with retailers who share our values and exceptionally high standards for progressive nutrition and ‘better-for-you’ foods.”
About Sprouts Farmers Market
True to its farm-stand heritage, Sprouts offers a unique grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspires wellness naturally with a carefully curated assortment of better-for-you products paired with purpose-driven people. The healthy grocer continues to bring the latest in wholesome, innovative products made with lifestyle-friendly ingredients such as organic, plant-based and gluten-free. Headquartered in Phoenix , and one of the fastest growing retailers in the country, Sprouts employs approximately 35,000 team members and operates more than 350 stores in 23 states nationwide.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . Else Toddler Nutrition was a #1 Best Seller on Amazon in the Baby/Toddler Formula Category in 2020. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Children’s Hospital of Colorado , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Posted by AGORACOM-JC
at 7:09 AM on Wednesday, December 23rd, 2020
Though the Company has executed contracts totaling approximately $775,000 in the calendar year, the value of these contracts will not be fully reflected in the fiscal year financials due to the fact some of the agreements were signed after August 31.
Moreover, given the SaaS business model of the Company, revenues are recognized pro-rata over the life of the term of each contract, which can range from 1 – 5 years.
Nonetheless, the approximate $775,000 record revenue from these contracts will be received and recognized by the Company.
VANCOUVER, BC , Dec. 23, 2020 – Imagine AR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables businesses, sports teams and organizations to create instant AR campaigns without a technical background, is pleased to provide investors with a corporate update for calendar 2020, the Company’s best year. Specifically, the Company set records in two key performance indicators (KPI’s):
Total Executed AR Contracts
$775,000 *
Total Proceeds from Financing
$6,000,000 (approximate)
* Approximate Augmented Reality Enterprise, White Label, and SDK contracts
ImagineAR CEO, Alen Paul Silverrstieen said “By every KPI, ImagineAR turned in its best calendar year performance ever. Despite the early negative impact to our sales pipeline as a result of COVID-19 shutting down live events, the pendulum swung quickly as sports teams, corporations and entertainers turned to augmented reality to generate new revenue opportunities through our platform’s ability to create direct mobile engagement and activations. We are very proud of our performance from both a sales and technology development point of view.”
The Company is filing its audited 2020 financials and MD&A for the fiscal year ended August 31, 2020 on SEDAR by the end of this month. Though the Company has executed contracts totaling approximately $775,000 in the calendar year, the value of these contracts will not be fully reflected in the fiscal year financials due to the fact some of the agreements were signed after August 31.
Moreover, given the SaaS business model of the Company, revenues are recognized pro-rata over the life of the term of each contract, which can range from 1 – 5 years. Nonetheless, the approximate $775,000 record revenue from these contracts will be received and recognized by the Company.
Silverrstieen added “Looking forward into 2021, though COVID-19 was a significant short-term catalyst in 2020, our pipeline clearly indicates it also accelerated the inevitable adoption of AR by 2-3 years, leading to our confident expectation that 2021 will see even greater increases than 2020. We fully expect to deliver news related to new contract wins in early 2021.”
Major New Global Clients
The Company had its best year of augmented reality contracts around the world in 2020.
Five Year White Label Contract with SlapitOnAR, a company owned and operated by true legends in the world of sports in the United States . CEO Mike Vanderjagt , NFL All-Pro Placekicker is the founder and his partners include Johnny Damon (MLB), Mike Modano (NHL), Troy Aikman (NFL), Steve Smith (NBA), and Cobi Jones (MLS).
Five Year White Label Contract with WaV Sports & Entertainment starting with a launch of the NFL Alumni Academy Subscription Mobile App early 2021.
Two Year Partnership with Valencia CF of La Liga in Spain installing the ImagineAR SDK in December 2020 .
Two Year Partnership with Royal Sociedad of La Liga in Spain installing the ImagineAR SDK in February 2021 .
Shoppers Drug Mart White Label Contract for Company-wide Training in 2021.
Business Partnership with India Music Superstar Ananya Birla to Launch ImagineAR for Consumers and Business in India . Ananya music videos have over 350 million views across all social platforms.
North American AR Consumer Campaigns
The Company launched three major consumer AR campaigns in North America .
Jacob “Stitch” Duran Promotion for the Fury vs. Wilder 2 Heavyweight Championship.
In partnership with the Broward Education Foundation, Flo Rida AR Campaign was launched in June 2020 . This AR campaign was covered in the United States by NBC, CBS, NPR, NY Times, Forbes, and many other media publications.
Free Virtual Santa Claus ImagineAR campaign was launched in December 2020 and has been already featured in media including CBS, The Guardian, KTLA, Military Families, and others.
$6,000,000 From Financing & Warrant Redemptions
Confidence in the Company’s augmented reality abilities was also demonstrated by the capital markets with ImagineAR receiving record proceeds from financing in 2020 of approximately $6,000,000 , including approximately $4,500,000 from the exercise of warrants over this summer. As a result, the Company is well financed for growth through to the end of 2021.
HOLIDAY WISHES
The Company wishes its investors in North America and across the world safe and happy holidays.
Most of all, ImagineAR extends its thanks and appreciation to all shareholders for their support and looks forward to achieving even greater things together in 2021.
This News Release is available on the company’s CEO Verified Discusion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
About ImagineAR
ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.
All trademarks of the property of respective owners.
We encourage you to do your own due diligence and ask your broker if ImagineAR Inc. (cse: IP) is suitable for your particular investment portfolio*.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward-looking information is based on certain key expectations and assumptions made by Imagination Park’s management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
